Serial Number 97259158
601

Registration Progress

Application Filed
Feb 9, 2022
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark:
Previous Owner: Emergent Operations Ireland Limited
Classes: 005

Trademark Image

Basic Information

Serial Number
97259158
Filing Date
February 9, 2022
Abandonment Date
December 20, 2022
Drawing Code
2000

Status Summary

Current Status
Inactive
Status Code
601
Status Date
Dec 21, 2022
Classes
005

Rights Holder

Emergent Operations Ireland Limited

03
Address
6th Floor, 6 Earlsfort Terrace
Dublin 2
IE

Ownership History

Emergent Operations Ireland Limited

Original Applicant
03
Dublin 2 IE

Legal Representation

Attorney
Virginia W. Marino

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

10 events
Date Code Type Description Documents
Dec 21, 2022 MAB1 E ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT Loading...
Dec 21, 2022 ABN1 O ABANDONMENT - EXPRESS MAILED Loading...
Dec 20, 2022 EXAR I TEAS EXPRESS ABANDONMENT RECEIVED Loading...
Nov 30, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 30, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 30, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 22, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 15, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 14, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 12, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; auto-injectors, syringes, intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of four rectangles, with each of the four rectangles intersecting in their middle every 45 degrees. One rectangle is entirely horizontal, and another is entirely vertical. The other two lie at 45 degree angles to form an asterisk shape. At every point of intersection, the color shade becomes darker, such that area where four rectangles intersect is in a darker shade than the areas where only two rectangles intersect, and in turn the areas where two rectangles intersect are darker than areas of no intersection. The upper-left point is in dark pink, the three points on the lower left are in pink, and the four points on the right side are in light blue.
Color Claim
The color(s) pink, dark pink, light blue, dark blue and purple is/are claimed as a feature of the mark.

Classification

International Classes
005